- 26.67% for the nine months of 2021 to SAR 5,282.34 million compared to the similar period of the previous year
Riyadh, Saudi Arabia : Dr. Sulaiman Al Habib Medical Services Group (the “Group”), Saudi Arabia’s largest private medical services provider, has announced its financial results for the 9-month period ended 30 September 2021.
The Group’s revenues grew by 13.08% in Q3-21 reaching SAR 1,836.35 million, with an increase of SAR 212.44 million compared to SAR 1,623.91 in the corresponding quarter of the previous year, as a result of the growth in all group segments.
For The Period Ended on 30th September 2021 (Nine Months), Revenues grew by 26.67% reaching SAR 5,282.34 million, with an increase of SAR 1,112.08 million compared to SAR 4,170.26 in the similar period of the previous year, as a result of the growth in all group segments. Net Income for the nine months period ended 30th September 2021 reached SAR 993.02 million.
Dr. Sulaiman Al Habib, Chairman of the Board of Directors at HMG, commented:
“Our commitment to HMG’s strategic pillars led us continue delivering remarkable financial and operational results, with strong growth of the top and bottom-line performance across Group’s segments. Revenue growth was mainly driven by the growth in hospital segment due to the increase in both the numbers of patients and inpatient occupancy in addition to Al Khobar Hospital continued revenue growth. Hospital segment growth was positively reflected in the increase in pharmacy segment sales compared to the similar period of the previous year. As we continue to roll out to innovate in healthcare technology and medical excellence for better patient experience.”
Dr. Al Habib concluded: “Our ambitions toward healthcare excellence have driven us to be the most trusted healthcare provider and the best patient experience. We are committed to developing and operating state-of-the-art medical facilities and providing innovative healthcare services to create value for patients and other stakeholders. All HMG hospitals in KSA were validated as stage 7 of HIMSS EMRAM, a recognition of the Group’s dedication to digital transformation; with Khobar accredited early this year. In addition, our hospitals were re-accredited by the Joint Commission International, while the group’s hospitals received certificates of appreciation from the Saudi Food and Drug Authority. The Group remains committed to its announced expansion plans according to the group’s prior strategic policy.”
Financials (9-months ended 30 September 2021)
-Ends-
About HMG
Dr. Sulaiman Al Habib Medical Services Group (HMG) is a private integrated healthcare provider with a 25+year track record for developing and operating healthcare facilities, pharmacies and associated services in Saudi Arabia and the GCC. The Group’s portfolio includes 7 hospitals in Saudi Arabia and the UAE, more than 1,900 beds and more than 1,370 clinics, one Medical Centre in Riyadh’s Diplomatic Quarter, and managing 1 medical centre in Bahrain.
HMG is a GCC leader in healthcare solutions, technology and systems. The Group offers comprehensive healthcare that is patient centric and supported by investment in first-class human capital and medical research. HMG consistently achieves industry-leading satisfaction rates across its primary, secondary and tertiary services.
HMG is listed on Saudi Stock Exchange “Tadawul” (Symbol: SULAIMAN ALHABIB: 4013), and is Saudi Arabia’s leading private healthcare provider.
Investor Relations & Media Enquiries
Investor Relations Dr. Sulaiman Al Habib Medical Services Group
Tel: +966 11 525 9999 Ext: 4919
Email: Investor.relations@drsulaimanalhabib.com
P.O. Box 301578
Riyadh 11372, Kingdom of Saudi Arabia
www.hmg.com
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
